Department of Cell and Chemical Biology, Leiden University Medical Centre, Leiden, The Netherlands.
Departamento de Genética, Facultad de Biología, Universidad de Sevilla, Sevilla, Spain.
Nat Commun. 2024 May 20;15(1):4292. doi: 10.1038/s41467-024-48427-6.
Deficiencies in the BRCA1 tumor suppressor gene are the main cause of hereditary breast and ovarian cancer. BRCA1 is involved in the Homologous Recombination DNA repair pathway and, together with BARD1, forms a heterodimer with ubiquitin E3 activity. The relevance of the BRCA1/BARD1 ubiquitin E3 activity for tumor suppression and DNA repair remains controversial. Here, we observe that the BRCA1/BARD1 ubiquitin E3 activity is not required for Homologous Recombination or resistance to Olaparib. Using TULIP2 methodology, which enables the direct identification of E3-specific ubiquitination substrates, we identify substrates for BRCA1/BARD1. We find that PCNA is ubiquitinated by BRCA1/BARD1 in unperturbed conditions independently of RAD18. PCNA ubiquitination by BRCA1/BARD1 avoids the formation of ssDNA gaps during DNA replication and promotes continuous DNA synthesis. These results provide additional insight about the importance of BRCA1/BARD1 E3 activity in Homologous Recombination.
BRCA1 肿瘤抑制基因的缺陷是遗传性乳腺癌和卵巢癌的主要原因。BRCA1 参与同源重组 DNA 修复途径,与 BARD1 一起形成具有泛素 E3 活性的异二聚体。BRCA1/BARD1 泛素 E3 活性对肿瘤抑制和 DNA 修复的相关性仍存在争议。在这里,我们观察到 BRCA1/BARD1 泛素 E3 活性对于同源重组或奥拉帕利耐药并不必需。使用 TULIP2 方法,该方法能够直接鉴定 E3 特异性泛素化底物,我们鉴定出 BRCA1/BARD1 的底物。我们发现 PCNA 在未受干扰的条件下通过 BRCA1/BARD1 被泛素化,独立于 RAD18。BRCA1/BARD1 对 PCNA 的泛素化可避免 DNA 复制过程中形成单链 DNA 缺口,并促进连续的 DNA 合成。这些结果为 BRCA1/BARD1 E3 活性在同源重组中的重要性提供了更多的见解。